GlassScriptPhysician profile
Jonathan B Bellotte
NPI 1275533119
$2,404.77
in general payments reported to CMS, 2019-2025
9 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.24 · 2022: $185 · 2023: $1,537 · 2024: $296 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146 · Travel and Lodging: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.44 |
| Travel and Lodging | $998.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,672.02 | 2022-2025 | Mazor X System, Pivox Oblique Lateral Spinal System, Cd Horizon Spinal System |
| Si-Bone, INC. | $142.29 | 2023 | |
| Amgen INC. | $140.36 | 2024 | Evenity |
| Ethicon US, LLC | $122.37 | 2024-2025 | Evarrest, Monocryl, Stratafix |
| Kuros Biosciences USA, INC | $97.87 | 2025 | Magnetos |
| Depuy Synthes Sales INC. | $89.21 | 2024 | Teligen |
| Brainlab, INC. | $66.41 | 2022 | |
| Boston Scientific Corporation | $42.14 | 2019 | |
| Stryker Corporation | $32.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bellotte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.